Ondansetron and metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to electrolyte imbalance

被引：0
|
作者：
Tsavaris, N.B.
Charalambidis, G.
Gamas, N.
Pagou, M.
Karabellis, A.
Mylonakis, N.
Benou, N.
Tsikalakis, D.
Kosmidis, P.
机构：
来源：
Acta Oncologica | 1995年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ONDANSETRON VERSUS METOCLOPRAMIDE AS ANTIEMETIC TREATMENT DURING CISPLATIN-BASED CHEMOTHERAPY - A PROSPECTIVE-STUDY WITH SPECIAL REGARD TO ELECTROLYTE IMBALANCE
    TSAVARIS, N
    CHARALAMBIDIS, G
    GANAS, N
    PAGOU, M
    KARABELLIS, A
    MYLONAKIS, N
    BENOU, N
    TSIKALAKIS, D
    KOSMIDIS, P
    ACTA ONCOLOGICA, 1995, 34 (02) : 243 - 246
  • [2] COMPARISON OF ANTIEMETIC ACTIVITY OF CHLOROPROMAZINE AND HIGH-DOSES OF METOCLOPRAMIDE IN CISPLATIN-BASED CHEMOTHERAPY
    TSAVARIS, NB
    PAPAIOANNOU, D
    BELDECOS, D
    KAKOLIRIS, S
    MYLONAKIS, N
    KARVOUNIS, N
    KOMITSOPOULOU, P
    KARAGIAOURIS, P
    SARMAS, J
    TZANNOU, I
    BACOYANNIS, C
    KOSMIDIS, P
    ACTA ONCOLOGICA, 1990, 29 (08) : 1005 - 1009
  • [3] The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy
    Lebeau, B
    Depierre, A
    Giovannini, M
    Riviere, A
    Kaluzinski, L
    Votan, B
    Hedouin, M
    dAllens, H
    Aubier, M
    Bachaud, JM
    Balmes, P
    Bernard, JP
    Biron, E
    Bonnaud, F
    BonsRosset, F
    Bouffette, P
    Boyer, J
    Brunet, R
    Caillaud, D
    Calais, G
    Capdeville, J
    CatryThomas, I
    Chaumier, P
    Chavaillon, JM
    Chevallier, B
    Clavier, J
    Constans, P
    Cupissol, D
    David, P
    Delzenne, A
    Derenne, JP
    Escamilla, R
    Eymard, JC
    Fabbro, M
    Fabre, V
    Fayolle, V
    Fournel, P
    Franchi, C
    Fruge, I
    Guerin, JC
    Gouerou, H
    Hadjadj, D
    Kelkel, E
    Lacroix, H
    LeBourgeois, JP
    Lebrun, D
    Lucas, P
    Martin, M
    Marty, M
    Mathieu, JP
    ANNALS OF ONCOLOGY, 1997, 8 (09) : 887 - 892
  • [4] PHASE-III DOUBLE-BLIND COMPARISON OF INTRAVENOUS ONDANSETRON AND METOCLOPRAMIDE AS ANTIEMETIC THERAPY FOR PATIENTS RECEIVING MULTIPLE-DAY CISPLATIN-BASED CHEMOTHERAPY
    SLEDGE, GW
    EINHORN, L
    NAGY, C
    HOUSE, K
    CANCER, 1992, 70 (10) : 2524 - 2528
  • [5] Acute renal failure during cisplatin-based chemotherapy: A prospective monocentric study
    Ben Kridis, Wala
    Lajnef, Mayssa
    Khanfir, Afef
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (06) : 1023 - 1028
  • [6] Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy
    Fumoleau, P
    Giovannini, M
    Rolland, F
    Votan, B
    Paillarse, JM
    Aubier
    Audhuy
    Baillet
    Balmes
    Bergerat
    Bernard
    Bobin
    Brunet
    Caillaud
    Carles
    Catimel
    Clavere
    Clavier
    Chomy
    Colin
    Coninx
    David
    Dutin
    Fruge
    Ganem
    Khayat
    Lafitte
    Laplaige
    Martin
    Miech
    Morvan
    Mousseau
    Muir
    Nouvet
    Peny
    Perpoint
    Pessey
    PujadeLauraine
    Romieu
    Sevin
    Stern
    Taulelle
    Tubiana
    Tubiana
    Vannetzel
    Verrelle
    Zylberberg
    ORAL ONCOLOGY, 1997, 33 (05): : 354 - 358
  • [7] Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy
    Gralla, RJ
    Navari, RM
    Hesketh, PJ
    Popovic, W
    Strupp, J
    Noy, J
    Einhorn, L
    Ettinger, D
    Bushnell, W
    Friedman, C
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1568 - 1573
  • [8] EVALUATION OF A COMBINATION ANTIEMETIC REGIMEN INCLUDING LV HIGH-DOSE METOCLOPRAMIDE, DEXAMETHASONE, AND DIPHENHYDRAMINE IN CISPLATIN-BASED CHEMOTHERAPY REGIMENS
    ROSELL, R
    ABADESTEVE, A
    RIBASMUNDO, M
    MORENO, I
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 909 - 910
  • [9] ANTIEMETIC EFFICACY OF HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND DEXAMETHASONE IN PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY - A RANDOMIZED CONTROLLED TRIAL
    SHINKAI, T
    SAIJO, N
    EGUCHI, K
    SASAKI, Y
    TAMURA, T
    TOMINAGA, K
    SAKURAI, M
    SANO, T
    TAITO, H
    TAKAHASHI, H
    NAKANO, H
    NAKAGAWA, K
    SUEMASU, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1986, 16 (03) : 279 - 287
  • [10] The impact of paclitaxel or cisplatin-based chemotherapy on sympathetic skin response: a prospective study
    Argyriou, AA
    Koutras, A
    Polychronopoulos, P
    Papapetropoulos, S
    Iconomou, G
    Katsoulas, G
    Makatsoris, T
    Kalofonos, HP
    Chroni, E
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (11) : 858 - 861
12345